| Circular RNAs: biogenesis, function and role in human diseases J Greene, AM Baird, L Brady, M Lim, SG Gray, R McDermott, SP Finn Frontiers in molecular biosciences 4, 38, 2017 | 536 | 2017 |
| Initiating oncogenic event determines gene-expression patterns of human breast cancer models KV Desai, N Xiao, W Wang, L Gangi, J Greene, JI Powell, R Dickson, ... Proceedings of the National Academy of Sciences 99 (10), 6967-6972, 2002 | 225 | 2002 |
| Targeting OXPHOS and the electron transport chain in cancer; Molecular and therapeutic implications J Greene, A Segaran, S Lord Seminars in Cancer Biology 86, 851-859, 2022 | 111 | 2022 |
| Circular RNAs are differentially expressed in prostate cancer and are potentially associated with resistance to enzalutamide J Greene, AM Baird, O Casey, L Brady, G Blackshields, M Lim, O o’Brien, ... Scientific Reports 9 (1), 10739, 2019 | 84 | 2019 |
| The role of anthracyclines in the treatment of early breast cancer J Greene, B Hennessy Journal of Oncology Pharmacy Practice 21 (3), 201-212, 2015 | 52 | 2015 |
| Secreted factors from metastatic prostate cancer cells stimulate mesenchymal stem cell transition to a pro‐tumourigenic ‘activated’state that enhances prostate cancer cell … SM Ridge, D Bhattacharyya, E Dervan, SD Naicker, AJ Burke, JM Murphy, ... International journal of cancer 142 (10), 2056-2067, 2018 | 32 | 2018 |
| RNAs as candidate diagnostic and prognostic markers of prostate cancer—from cell line models to liquid biopsies MCJ Lim, AM Baird, J Aird, J Greene, D Kapoor, SG Gray, R McDermott, ... Diagnostics 8 (3), 60, 2018 | 22 | 2018 |
| Platelet cloaking of circulating tumour cells in patients with metastatic prostate cancer: Results from ExPeCT, a randomised controlled trial L Brady, B Hayes, G Sheill, AM Baird, E Guinan, B Stanfill, T Vlajnic, ... PLoS One 15 (12), e0243928, 2020 | 21 | 2020 |
| Differential CircRNA expression signatures may serve as potential novel biomarkers in prostate cancer J Greene, AM Baird, M Lim, J Flynn, C McNevin, L Brady, O Sheils, ... Frontiers in cell and developmental biology 9, 605686, 2021 | 18 | 2021 |
| Linking circulating serum proteins with clinical outcomes in esophageal adenocarcinoma—an emerging role for chemokines NE Donlon, A Sheppard, M Davern, F O’Connell, JJ Phelan, R Power, ... Cancers 12 (11), 3356, 2020 | 18 | 2020 |
| Circulating tumour cell numbers correlate with platelet count and circulating lymphocyte subsets in men with advanced prostate cancer: Data from the ExPeCT clinical trial … B Hayes, L Brady, G Sheill, AM Baird, E Guinan, B Stanfill, J Dunne, ... Cancers 13 (18), 4690, 2021 | 16 | 2021 |
| Radium-223 in combination with enzalutamide in metastatic castration-resistant prostate cancer: a multi-centre, phase II open-label study RS McDermott, J Greene, J McCaffrey, I Parker, S Helanova, AM Baird, ... Therapeutic Advances in Medical Oncology 13, 17588359211042691, 2021 | 14 | 2021 |
| Prostate cancer-derived holoclones: a novel and effective model for evaluating cancer stemness L Flynn, MP Barr, AM Baird, P Smyth, OM Casey, G Blackshields, ... Scientific Reports 10 (1), 11329, 2020 | 13 | 2020 |
| Circular RNAs: biogenesis, function and role in human diseases. Front Mol Biosci. 2017; 4: 38 J Greene, AM Baird, L Brady, M Lim, SG Gray, R McDermott, SP Finn External Resources Pubmed/Medline (NLM) Crossref (DOI), 2017 | 12 | 2017 |
| The ExPeCT (Examining Exercise, Prostate Cancer and Circulating Tumour Cells) trial: study protocol for a randomised controlled trial G Sheill, L Brady, E Guinan, B Hayes, O Casey, J Greene, T Vlajnic, ... Trials 18, 1-12, 2017 | 10 | 2017 |
| Maintaining a medical oncology service during the COVID-19 Pandemic J Greene, WJ Mullally, Y Ahmed, M Khan, P Calvert, A Horgan, E Jordan, ... Ir Med J 113 (5), 77, 2020 | 8 | 2020 |
| hsa_circ_0001275 is one of a number of circRNAs dysregulated in enzalutamide resistant prostate cancer and confers enzalutamide resistance in vitro MCJ Lim, AM Baird, J Greene, C McNevin, K Ronan, P Podlesniy, ... Cancers 13 (24), 6383, 2021 | 7 | 2021 |
| Malignant pleural disease LM Piggott, C Hayes, J Greene, DB Fitzgerald Breathe 19 (4), 2024 | 6 | 2024 |
| ExPeCT: a randomised trial examining the impact of exercise on quality of life in men with metastatic prostate cancer G Sheill, L Brady, B Hayes, AM Baird, E Guinan, R Vishwakarma, ... Supportive Care in Cancer 31 (5), 292, 2023 | 5 | 2023 |
| Real world experience with pembrolizumab and nivolumab for treatment of non-small cell lung cancer (NSCLC) in an Irish Regional Cancer Center. C Dennehy, W Mullally, C Goggin, JP Gleeson, JP Greene, DG Power, ... Journal of Clinical Oncology 36 (15_suppl), e21196-e21196, 2018 | 5 | 2018 |
